191 related articles for article (PubMed ID: 16640832)
1. Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations.
Blanchard N; Hewitt NJ; Silber P; Jones H; Coassolo P; Lavé T
J Pharm Pharmacol; 2006 May; 58(5):633-41. PubMed ID: 16640832
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Zanelli U; Caradonna NP; Hallifax D; Turlizzi E; Houston JB
Drug Metab Dispos; 2012 Jan; 40(1):104-10. PubMed ID: 21998403
[TBL] [Abstract][Full Text] [Related]
3. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
Riley RJ; McGinnity DF; Austin RP
Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fresh and cryopreserved rat hepatocyte suspensions for the prediction of in vitro intrinsic clearance.
Griffin SJ; Houston JB
Drug Metab Dispos; 2004 May; 32(5):552-8. PubMed ID: 15100178
[TBL] [Abstract][Full Text] [Related]
5. Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes.
Blanchard N; Richert L; Notter B; Delobel F; David P; Coassolo P; Lavé T
Eur J Pharm Sci; 2004 Oct; 23(2):189-99. PubMed ID: 15451007
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intrinsic metabolic clearance in fresh and cryopreserved human hepatocytes.
Floby E; Johansson J; Hoogstraate J; Hewitt NJ; Hill J; Sohlenius-Sternbeck AK
Xenobiotica; 2009 Sep; 39(9):656-62. PubMed ID: 19622023
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clearance predictions using primary cultures and suspensions of human hepatocytes.
Blanchard N; Alexandre E; Abadie C; Lavé T; Heyd B; Mantion G; Jaeck D; Richert L; Coassolo P
Xenobiotica; 2005 Jan; 35(1):1-15. PubMed ID: 15788364
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds.
Sohlenius-Sternbeck AK; Afzelius L; Prusis P; Neelissen J; Hoogstraate J; Johansson J; Floby E; Bengtsson A; Gissberg O; Sternbeck J; Petersson C
Xenobiotica; 2010 Sep; 40(9):637-49. PubMed ID: 20624033
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance.
Brown HS; Griffin M; Houston JB
Drug Metab Dispos; 2007 Feb; 35(2):293-301. PubMed ID: 17132764
[TBL] [Abstract][Full Text] [Related]
10. A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum.
Shibata Y; Takahashi H; Ishii Y
Drug Metab Dispos; 2000 Dec; 28(12):1518-23. PubMed ID: 11095592
[TBL] [Abstract][Full Text] [Related]
11. Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo.
Soars MG; Grime K; Sproston JL; Webborn PJ; Riley RJ
Drug Metab Dispos; 2007 Jun; 35(6):859-65. PubMed ID: 17344337
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance.
McGinnity DF; Soars MG; Urbanowicz RA; Riley RJ
Drug Metab Dispos; 2004 Nov; 32(11):1247-53. PubMed ID: 15286053
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes.
Lu C; Li P; Gallegos R; Uttamsingh V; Xia CQ; Miwa GT; Balani SK; Gan LS
Drug Metab Dispos; 2006 Sep; 34(9):1600-5. PubMed ID: 16790553
[TBL] [Abstract][Full Text] [Related]
14. Use of intrinsic clearance for prediction of human hepatic clearance.
Chao P; Uss AS; Cheng KC
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
[TBL] [Abstract][Full Text] [Related]
15. A novel relay method for determining low-clearance values.
Di L; Trapa P; Obach RS; Atkinson K; Bi YA; Wolford AC; Tan B; McDonald TS; Lai Y; Tremaine LM
Drug Metab Dispos; 2012 Sep; 40(9):1860-5. PubMed ID: 22645091
[TBL] [Abstract][Full Text] [Related]
16. Prediction of metabolic clearance using cryopreserved human hepatocytes: kinetic characteristics for five benzodiazepines.
Hallifax D; Rawden HC; Hakooz N; Houston JB
Drug Metab Dispos; 2005 Dec; 33(12):1852-8. PubMed ID: 16174807
[TBL] [Abstract][Full Text] [Related]
17. Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method.
Shibata Y; Takahashi H; Chiba M; Ishii Y
Drug Metab Dispos; 2002 Aug; 30(8):892-6. PubMed ID: 12124306
[TBL] [Abstract][Full Text] [Related]
18. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
Deshmukh SV; Harsch A
J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
[TBL] [Abstract][Full Text] [Related]
19. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes.
Hutzler JM; Yang YS; Albaugh D; Fullenwider CL; Schmenk J; Fisher MB
Drug Metab Dispos; 2012 Feb; 40(2):267-75. PubMed ID: 22031625
[TBL] [Abstract][Full Text] [Related]
20. Prediction of in vitro intrinsic clearance from hepatocytes: comparison of suspensions and monolayer cultures.
Griffin SJ; Houston JB
Drug Metab Dispos; 2005 Jan; 33(1):115-20. PubMed ID: 15608354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]